GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BUE:LLY) » Definitions » Investments And Advances

Eli Lilly and Co (BUE:LLY) Investments And Advances : ARS3,248,059 Mil (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co Investments And Advances?

Eli Lilly and Co's Investments And Advances for the quarter that ended in Dec. 2024 was ARS3,248,059 Mil.

Eli Lilly and Co's quarterly Investments And Advances increased from Jun. 2024 (ARS2,576,891 Mil) to Sep. 2024 (ARS3,041,790 Mil) and increased from Sep. 2024 (ARS3,041,790 Mil) to Dec. 2024 (ARS3,248,059 Mil).

Eli Lilly and Co's annual Investments And Advances increased from Dec. 2022 (ARS486,487 Mil) to Dec. 2023 (ARS1,101,844 Mil) and increased from Dec. 2023 (ARS1,101,844 Mil) to Dec. 2024 (ARS3,248,059 Mil).

Eli Lilly and Co Investments And Advances Historical Data

The historical data trend for Eli Lilly and Co's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Investments And Advances Chart

Eli Lilly and Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 241,438.18 324,440.47 486,486.76 1,101,844.20 3,248,059.03

Eli Lilly and Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,101,844.20 2,600,713.29 2,576,890.76 3,041,789.97 3,248,059.03

Eli Lilly and Co Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.

Eli Lilly and Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (BUE:LLY) » Definitions » Investments And Advances
Comparable Companies
JNJ ABBV MRK AMGN PFE GILD BMY BIIB OGN AMRN OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN XPAR:SAN TSE:4519 LSE:GSK TSE:4568 SHSE:600276 XTER:BAYN
Traded in Other Exchanges
LLY:USA LLY:Mexico 1LLY:Italy LLY0:Germany LLY:Germany LLY:Germany LLY:Germany LLY:Germany LLYCL:Chile LLY:Switzerland LLY:Canada LILY34:Brazil LLYC:Austria
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Website
https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.